Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
1.990
-0.030 (-1.49%)
At close: Oct 13, 2026, 4:00 PM EDT
1.990
0.00 (0.00%)
Pre-market: Oct 14, 2026, 8:57 AM EDT
Grace Therapeutics Market Cap
Grace Therapeutics has a market cap or net worth of $41.86 million as of October 13, 2026. It is the 31,615th most valuable company in the world and the 4,771st biggest in the United States. Its market cap has increased by 1.36% in one year.
Market Cap
41.86M
Enterprise Value
28.11M
1-Year Change
1.36%
Global Rank
Country Rank
#4,771 United States
Category
ChartMarket Cap Chart
Since January 9, 2015, Grace Therapeutics's market cap has decreased from $6.81B to $41.86M, a decrease of -99.39%. That is a compound annual growth rate of -35.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 41.90M | -14.31% |
| Dec 31, 2025 | 48.90M | 29.02% |
| Dec 31, 2024 | 37.90M | 39.34% |
| Dec 29, 2023 | 27.20M | 21.43% |
| Dec 30, 2022 | 22.40M | -59.86% |
| Dec 31, 2021 | 55.80M | 77.14% |
| Dec 31, 2020 | 31.50M | -84.91% |
| Dec 31, 2019 | 208.70M | 584.26% |
| Dec 31, 2018 | 30.50M | 119.42% |
| Dec 29, 2017 | 13.90M | 3.73% |
| Dec 30, 2016 | 13.40M | -99.80% |
| Jan 9, 2015 | 6.81B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Werewolf Therapeutics | 47.71M |
| Celularity | 47.70M |
| eXoZymes | 46.87M |
| Apollomics | 46.82M |
| Dogwood Therapeutics | 46.57M |
| BioStem Technologies | 45.35M |
| Instil Bio | 44.63M |
| Veru Inc. | 41.01M |